Journal profile · INFECTIOUS DISEASES
Current HIV/AIDS Reports
ISSN 1548-3568 · eISSN 1548-3576 · Springer US · UNITED STATES · 6 issues per year · Founded 2004
Current HIV/AIDS Reports: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.33; hybrid open access; APC about USD 4,190; median 168 days to acceptance (15 articles, last 24 months); 47 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current HIV/AIDS Reports is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV/AIDS Research and Interventions, HIV Research and Treatment and HIV, Drug Use, Sexual Risk, together about 51.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of HIV/AIDS. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antiretroviral therapies, behavioral aspects of management, and metabolic complications and comorbidity. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Paul A. VolberdingPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named United States 30, Thailand 2, Mainland China 1, United Kingdom 1, Italy 1 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV/AIDS Research and InterventionsMedicine25.7%
- HIV Research and TreatmentImmunology and Microbiology16.1%
- HIV, Drug Use, Sexual RiskMedicine9.9%
- HIV-related health complications and treatmentsMedicine9.8%
- HIV/AIDS drug development and treatmentMedicine7.8%
- Adolescent Sexual and Reproductive HealthHealth Professions5.7%
- Sex work and related issuesSocial Sciences3.2%
- Hepatitis C virus researchMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.33LetPub ·
- Impact factor (publisher) 2025
- 4.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.5Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- SJR 2026-06
- 1.57LetPub ·
- SNIP 2026-06
- 1.55LetPub ·
- h-index
- 46LetPub ·
- h-index
- 99OpenAlex ·
- i10-index
- 699OpenAlex ·
- 2-year mean citedness
- 5.36OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 40.68%LetPub ·
Volume
- Articles per year
- 45LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 325,000Publisher website ·
Articles by year OpenAlex count · 935 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 16 | 40 |
| 2025 | 47 | 32 | 210 |
| 2024 | 33 | 26 | 329 |
| 2023 | 42 | 26 | 609 |
| 2022 | 51 | 42 | 1,314 |
| 2021 | 57 | 46 | 1,635 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
168 daysMedian, submission to acceptance · P25–P75 89 days – 234 days
- Acceptance to online
- median 18 days (58 articles)
- Submission to online
- median 193 days
- Sample
- 15 articles with submission and acceptance dates (58 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,290 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted2
- commentaryReviews and Invited Commentaries, Back to topLength not stated
- reviewReviews and Invited Commentaries, Back to topLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current HIV/AIDS Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- 6 issues per year
- Founded
- 2004
- ISSN
- 1548-3568
- Electronic ISSN
- 1548-3576
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current HIV/AIDS Reports
What CAS zone is Current HIV/AIDS Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current HIV/AIDS Reports is in Zone 2 of Medicine, and in Zone 2 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current HIV/AIDS Reports?
The latest impact factor listed by LetPub is 4.33; CiteScore 8, h-index 99.
How long does peer review take at Current HIV/AIDS Reports?
Based on the dates recorded on 15 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 168 days (interquartile range 89–234 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current HIV/AIDS Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current HIV/AIDS Reports based?
Of the 40 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (30), Thailand (2) and Mainland China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Current HIV/AIDS Reports?
According to LetPub and DOAJ records, Current HIV/AIDS Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Current HIV/AIDS Reports open access, and what is the APC?
Current HIV/AIDS Reports is a hybrid journal. For open-access publication: APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .